Literature DB >> 15245365

Consensus guidelines in diagnosis and treatment of atopic dermatitis.

L F Eichenfield1.   

Abstract

Atopic dermatitis is a common condition of great health significance. Consensus-driven guidelines of care or specific practice parameters may be useful, as are treatment algorithms based upon disease severity. Development of consensus guidelines on diagnosis and treatment of atopic dermatitis are discussed, and disease-severity-based guidelines of care proposed. Copyright 2004 Blackwell Munksgaard

Entities:  

Mesh:

Year:  2004        PMID: 15245365     DOI: 10.1111/j.1398-9995.2004.00569.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  12 in total

Review 1.  Efficacy of bleach baths in reducing severity of atopic dermatitis: A systematic review and meta-analysis.

Authors:  Rishi Chopra; Paras P Vakharia; Ryan Sacotte; Jonathan I Silverberg
Journal:  Ann Allergy Asthma Immunol       Date:  2017-11       Impact factor: 6.347

2.  Pathophysiology of atopic dermatitis: Clinical implications.

Authors:  Jihyun Kim; Byung Eui Kim; Donald Y M Leung
Journal:  Allergy Asthma Proc       Date:  2019-03-01       Impact factor: 2.587

3.  Tight junction defects in patients with atopic dermatitis.

Authors:  Anna De Benedetto; Nicholas M Rafaels; Laura Y McGirt; Andrei I Ivanov; Steve N Georas; Chris Cheadle; Alan E Berger; Kunzhong Zhang; Sadasivan Vidyasagar; Takeshi Yoshida; Mark Boguniewicz; Tissa Hata; Lynda C Schneider; Jon M Hanifin; Richard L Gallo; Natalija Novak; Stephan Weidinger; Terri H Beaty; Donald Y M Leung; Kathleen C Barnes; Lisa A Beck
Journal:  J Allergy Clin Immunol       Date:  2010-12-15       Impact factor: 10.793

Review 4.  Topical calcineurin inhibitors in pediatric atopic dermatitis: a critical analysis of current issues.

Authors:  Seth J Orlow
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

Review 5.  A safety assessment of topical calcineurin inhibitors in the treatment of atopic dermatitis.

Authors:  Mark Lebwohl; Tara Gower
Journal:  MedGenMed       Date:  2006-10-10

6.  Aldo-keto reductase 1C3 is expressed in differentiated human epidermis, affects keratinocyte differentiation, and is upregulated in atopic dermatitis.

Authors:  Alon Mantel; Amanda B Carpenter-Mendini; Joanne B Vanbuskirk; Anna De Benedetto; Lisa A Beck; Alice P Pentland
Journal:  J Invest Dermatol       Date:  2011-12-15       Impact factor: 8.551

7.  Impaired Tight Junctions in Atopic Dermatitis Skin and in a Skin-Equivalent Model Treated with Interleukin-17.

Authors:  Takuo Yuki; Megumi Tobiishi; Ayumi Kusaka-Kikushima; Yukiko Ota; Yoshiki Tokura
Journal:  PLoS One       Date:  2016-09-02       Impact factor: 3.240

8.  A Derivative of Butyric Acid, the Fermentation Metabolite of Staphylococcus epidermidis, Inhibits the Growth of a Staphylococcus aureus Strain Isolated from Atopic Dermatitis Patients.

Authors:  Supitchaya Traisaeng; Deron Raymond Herr; Hsin-Jou Kao; Tsung-Hsien Chuang; Chun-Ming Huang
Journal:  Toxins (Basel)       Date:  2019-05-31       Impact factor: 4.546

9.  Probiotics for treating eczema.

Authors:  Areti Makrgeorgou; Jo Leonardi-Bee; Fiona J Bath-Hextall; Dedee F Murrell; Mimi Lk Tang; Amanda Roberts; Robert J Boyle
Journal:  Cochrane Database Syst Rev       Date:  2018-11-21

10.  ΔNp63 regulates IL-33 and IL-31 signaling in atopic dermatitis.

Authors:  J M Rizzo; A Oyelakin; S Min; K Smalley; J Bard; W Luo; J Nyquist; E Guttman-Yassky; T Yoshida; A De Benedetto; L A Beck; S Sinha; R-A Romano
Journal:  Cell Death Differ       Date:  2016-01-15       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.